This brand name is authorized in Ecuador.
The drug EPTAVIS contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
T8F3MOB0CG - STREPTOCOCCUS THERMOPHILUS
|
2
|
UNII
IO1WP3918D - BIFIDOBACTERIUM SPP.
|
3
|
UNII
1PRR1V42V5 - LACTOBACILLUS ACIDOPHILUS
|
4
|
UNII
QFC21096ON - LACTIPLANTIBACILLUS PLANTARUM
|
5
|
UNII
N1G291SC6Q - LACTICASEIBACILLUS PARACASEI
|
6
|
UNII
HU1W4L947H - LACTOBACILLUS DELBRUECKII BULGARICUS
|
7
|
UNII
34YYS7G16P - ENTEROCOCCUS FAECIUM
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A07FA01 | Lactic acid producing organisms | A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07F Antidiarrheal microorganisms → A07FA Antidiarrheal microorganisms |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 25.629-04-04, 26.365-05-05 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.